Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

 Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

Abbott and Tandem Collaborate to Explore Integrated Diabetes Solutions Improving Diabetes Management

Shots:

  • The companies collaborated to develop & commercialize integrated diabetes solutions combining Abbott’s FreeStyle Libre System with the Tandem’s t:slim X2 insulin pump expanding choice for the patients to manage diabetes
  • The focus of the agreement is to combine Abbott’s and Tandem’s leadership and expertise to provide people with new ways to manage their diabetes, integrating easily into their daily lives
  • Abbott’s FreeStyle Libre is a sensor-based glucose monitoring system, reads glucose levels via sensor that can be worn on the back of the upper arm eliminating the need for fingerstick. The Tandem’s t:slim X2 is an alternate controller enabled (ACE) infusion pumps and is the first system to approved as compatible with interoperable continuous glucose monitoring (iCGM) devices

Click here to­ read full press release/ article | Ref: Abbott | Image: ESD Global

Shiwani Sharma

Shiwani Sharma is a Senior Editor at PharmaShots. She has in-depth knowledge of lifesciences industry including pharma and biotech sectors. She also covers news in field of Digital Health, Medtech and regulatory approvals from the US FDA, EU, and other global regulatory bodies in the industry. Additionally, she also writes Whitepapers, analysis reports, blogs on pharma and biotech industry. She is graduate in Biotechnology. She can be contacted on shiwani@pharmashots.com

Related post